secwatch.observer — SEC 8-K summary
======================================

Issuer:     OnKure Therapeutics, Inc. (OKUR)
CIK:        0001637715
Form:       8-K
Filed at:   2024-02-23T23:59:59+00:00
Accession:  0000950170-24-019338
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 2.05
LLM model:  deepseek-v4-flash:cloud@v2

Reneo Pharma to cut ~20% workforce, expects $1.7M severance charges in Q1 2024
------------------------------------------------------------------------------

- Second workforce reduction of approximately 20% to be completed by February 29, 2024.
- Estimated $1.7 million in cash severance and employee termination costs in Q1 2024.
- Follows prior reduction announced December 14, 2023 as part of cost-saving plan.
- Actual charges may differ due to assumptions and potential additional costs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1637715/000095017024019338/0000950170-24-019338-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1637715/000095017024019338/rphm-20240220.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-019338

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer